Outlook Therapeutics Inc.
(OTLK) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
2.40
0.63%
Pre-market Jan 07, 2025, 04:33 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
PE Ratio | -0.00 | -0.94 | -3.92 | -6.23 | -1.48 | -0.79 | -3.09 | -0.85 | -1.37 | -1.35 | -4.4 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 3.33 | 46.19 | 8.63 | 24.55 | 12.30 | 6.67 |
PB Ratio | -0.00 | -3.83 | 29.62 | 71.91 | 18.49 | -2.52 | -6.85 | -1.07 | -14.07 | -2.73 | -2.11 |
P/FCF Ratio | -0.00 | -1.29 | -4.57 | -6.11 | -1.64 | -0.83 | -3.98 | -2.08 | -1.57 | -1.77 | -6.43 |
P/OCF Ratio | -0.00 | -1.29 | -4.57 | -6.11 | -1.64 | -0.84 | -4.32 | -2.12 | -1.61 | -2.34 | -8.6 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -3.96 | -10.7 | -4.07 | -15.26 | -5.26 | -0.78 |
Debt / Equity Ratio | -0.00 | -2.46 | 1.25 | 2.56 | 1.62 | -1.06 | -0.86 | -0.59 | -1.43 | -0.84 | -0.7 |
Quick Ratio | 0.64 | 0.66 | 1.39 | 3.19 | 1.13 | 0.67 | 0.10 | 0.14 | 0.28 | 0.16 | 0.41 |
Current Ratio | 0.64 | 0.66 | 1.39 | 3.19 | 1.13 | 0.67 | 0.10 | 0.14 | 0.28 | 0.16 | 0.41 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.48 | 0.14 | 0.18 | 0.13 | 0.45 | 0.26 |
Interest Coverage | -22.71 | -34.06 | -42.4 | -55.26 | -20.98 | -10.47 | -6.54 | -6.38 | -35.26 | -20.27 | -13.75 |
Return on Equity (ROE) | 1.03 | 4.09 | -7.56 | -11.54 | -12.47 | 3.21 | 2.22 | 1.26 | 10.26 | 2.01 | 0.48 |
Return on Assets (ROA) | -2.61 | -1.83 | -2.32 | -2.33 | -1.79 | -2.01 | -2.07 | -1.87 | -2.25 | -4.08 | -0.39 |
Return on Capital (ROIC) | 5.22 | 3.68 | -7.17 | -3.22 | -9.58 | 11.50 | 2.61 | 4.48 | -15.83 | 5.41 | 6.10 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | 13.23K | 516.10 | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -40.92K | -437.2 | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 99.71% | 99.40% | 99.38% | 98.90% | 99.26% | 99.84% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -423.81% | -1.49K% | -1.02K% | -1.79K% | -908.05% | -151.73% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -465.68% | -1.09K% | -1.01K% | -1.79K% | -936.15% | -146.88% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -445.6% | -824.09% | -941.36% | -1.74K% | -892.13% | -136.92% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -401.75% | -1.16K% | -414.46% | -1.56K% | -695.13% | -103.72% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -381.85% | -867.82% | -787.87% | -1.64K% | -857.18% | -127.22% |